Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Plutavimab is a humanized IgG1-κ monoclonal antibody targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) glycoprotein [1] [2].
説明 | Plutavimab is a humanized IgG1-κ monoclonal antibody targeting the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) glycoprotein [1] [2]. |
別名 | COVI-AMG, STI-2020 |
分子量 | N/A |
CAS No. | 2529854-88-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Plutavimab 2529854-88-2 Microbiology/Virology SARS-CoV COVI-AMG STI-2020 Inhibitor inhibitor inhibit